219 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
IONS Ionis Pharmaceuticals, Inc. $48.21 $6.62B N/A
Article Searches
Biogen (BIIB) Q2 Earnings & Sales Beat Estimates, Shares Up http://www.zacks.com/stock/news/313015/biogen-biib-q2-earnings-sales-beat-estimates-shares-up?cid=CS-ZC-FT-313015 Jul 24, 2018 - Biogen (BIIB) beats estimates on both counts in the second quarter. The company's multiple sclerosis drugs' sales up sequentially amid competition.
Pfizer Gets FDA's Priority Review for Rare Disease Candidate http://www.zacks.com/stock/news/347373/pfizer-gets-fdas-priority-review-for-rare-disease-candidate?cid=CS-ZC-FT-347373 Jan 15, 2019 - FDA grants priority review to Pfizer's (PFE) regulatory filing looking for approval of pipeline candidate, tafamidis to treat transthyretin amyloid cardiomyopathy.
Ironwood Commences Phase I Study on IW-6463 for CNS Disorders http://www.zacks.com/stock/news/349476/ironwood-commences-phase-i-study-on-iw-6463-for-cns-disorders?cid=CS-ZC-FT-349476 Jan 24, 2019 - Ironwood (IRWD) begins a phase I study on CNS-penetrant soluble guanylate cyclase stimulator, IW-6463, for treating severe CNS disorders.
Has Ionis Pharmaceuticals (IONS) Outpaced Other Medical Stocks This Year? http://www.zacks.com/stock/news/349996/has-ionis-pharmaceuticals-ions-outpaced-other-medical-stocks-this-year?cid=CS-ZC-FT-349996 Jan 28, 2019 - Is (IONS) Outperforming Other Medical Stocks This Year?
Analysts Estimate Ionis Pharmaceuticals (IONS) to Report a Decline in Earnings: What to Look Out for http://www.zacks.com/stock/news/355722/analysts-estimate-ionis-pharmaceuticals-ions-to-report-a-decline-in-earnings-what-to-look-out-for?cid=CS-ZC-FT-355722 Feb 20, 2019 - Ionis Pharmaceuticals (IONS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Intuitive Surgical Gets FDA Nod for Ion Endoluminal System http://www.zacks.com/stock/news/355677/intuitive-surgical-gets-fda-nod-for-ion-endoluminal-system?cid=CS-ZC-FT-355677 Feb 20, 2019 - The regulatory go-ahead for the Ion platform is likely to provide Intuitive Surgical (ISRG) a competitive edge in the minimally-invasive-care space.
4 Large-Cap Stocks Worth Looking Into Right Now http://www.zacks.com/stock/news/388148/4-large-cap-stocks-worth-looking-into-right-now?cid=CS-ZC-FT-388148 Apr 18, 2019 - Here are 4 large-cap stocks from varied industries that may be worth your money.
Ion Geophysical (IO) Reports Q1 Loss, Tops Revenue Estimates http://www.zacks.com/stock/news/407018/ion-geophysical-io-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-407018 May 01, 2019 - Ion Geophysical (IO) delivered earnings and revenue surprises of -97.40% and 8.06%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Ionis Pharmaceuticals (IONS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release http://www.zacks.com/stock/news/407704/ionis-pharmaceuticals-ions-earnings-expected-to-grow-what-to-know-ahead-of-next-weeks-release?cid=CS-ZC-FT-407704 May 02, 2019 - Ionis Pharmaceuticals (IONS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Pages: 1...171819202122

<<<Page 22